Barriers to the utilization of thrombolysis for acute ischaemic stroke

Publisher:
Wiley-Blackwell
Publication Type:
Journal Article
Citation:
Journal of Clinical Pharmacy & Therapeutics, 2012, 37 pp. 399 - 409
Issue Date:
2012-01
Full metadata record
Files in This Item:
Filename Description Size
Thumbnail2011006080OK.pdfPublished Version581.06 kB
Adobe PDF
Thrombolysis is currently the only evidence-based pharmacological treatment available for acute ischaemic stroke (AIS); however, its current utilization is suboptimal (administered to <3% of AIS patients). The aim of this article was to identify the potential barriers to the use of thrombolysis via a review of the available literature. Methods: Medline, Embase, International Pharmaceutical Abstracts and Google Scholar were searched to identify relevant original articles, review papers and other literature published in the period 1995-2011. Results and Discussion: Several barriers to the utilization of thrombolysis in stroke have been identified in the literature and can be broadly classified as 'preadmission' barriers and 'post-admission' barriers.The most effective interventions appear to be those comprising several strategies and those that target more than one barrier simultaneously. Therefore, optimal utilization of thrombolysis requires a systematic, integrated multidisciplinary approach across the continuum of acute care.
Please use this identifier to cite or link to this item: